{"schema_version":"secwatch.filing_event.v1","accession":"0001380106-26-000029","form_type":"8-K","ticker":"RPID","cik":"0001380106","company_name":"RAPID MICRO BIOSYSTEMS, INC.","filed_at":"2026-03-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.952208+00:00","generated_at":"2026-05-15T13:09:42.388671+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Rapid Micro reports record Q4 revenue $11.3M (+37% YoY); 2026 guidance $37-41M; Samsung Biologics expands Growth Direct","bullets":["Q4 total revenue $11.3M (+37% YoY); product revenue $9.3M (+78%).","FY 2025 revenue $33.6M (+20% YoY); net loss $47.1M ($1.05/share).","FY 2026 guidance: revenue $37-41M, 30-38 system placements, gross margin ~20%.","Samsung Biologics placed multi-system Growth Direct order in Q1 2026, following Amgen's Q4 2025 multi-system order.","Cash position $39M; $25M unused under Trinity Capital debt facility."],"urls":{"canonical":"https://secwatch.observer/filing/0001380106-26-000029","json":"https://secwatch.observer/filing/0001380106-26-000029.json","markdown":"https://secwatch.observer/filing/0001380106-26-000029.md","text":"https://secwatch.observer/filing/0001380106-26-000029.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1380106/000138010626000029/0001380106-26-000029-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1380106/000138010626000029/rpid-20260312.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T13:09:42.388671+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"033e83c9eb7ee021eb089bb3532b35b55736fee4","claim":"RAPID MICRO BIOSYSTEMS, INC. reported full year 2025 results: revenue $33.6 million, net income $47.1 million, EPS $1.05.","evidence_excerpt":"Total revenue for the full year was $33.6 million in 2025, compared to $28.1 million in 2024, representing an increase of 20%.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1380106/000138010626000029/0001380106-26-000029-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full year 2025"},{"label":"Revenue","value":"$33.6 million"},{"label":"Net income","value":"$47.1 million"},{"label":"EPS","value":"$1.05"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"340f6071e0d8daf00e10759cf6004b3df27d3cf3","claim":"RAPID MICRO BIOSYSTEMS, INC. reported fourth quarter of 2025 results: revenue $11.3 million, net income $12.5 million, EPS $0.28.","evidence_excerpt":"Total revenue for the fourth quarter of 2025 was $11.3 million, compared to $8.2 million in the fourth quarter of 2024, representing an increase of 37%.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1380106/000138010626000029/0001380106-26-000029-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter of 2025"},{"label":"Revenue","value":"$11.3 million"},{"label":"Net income","value":"$12.5 million"},{"label":"EPS","value":"$0.28"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"b381496efa8ba6c7e115b64efb865211c1801a4f","claim":"RAPID MICRO BIOSYSTEMS, INC. reported full year 2026 results: revenue $37.0 million to $41.0 million. Guidance initiated.","evidence_excerpt":"For the full year 2026, the Company expects total revenue in the range of $37.0 million to $41.0 million including a range of 30 to 38 Growth Direct system placements and gross margins of approximately 20%.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1380106/000138010626000029/0001380106-26-000029-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"full year 2026"},{"label":"Revenue","value":"$37.0 million to $41.0 million"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}